Bausch Health Companies Inc. and its gastroenterology business, Salix Pharmaceuticals, today announced the winners of its 2021 Salix Gastrointestinal Health Scholars Program.
Ten Students Affected by Gastrointestinal Disease Will Each Receive a $10,000 Scholarship |
[22-July-2021] |
LAVAL, Quebec, July 22, 2021 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix Pharmaceuticals, Ltd., (“Salix”), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced the winners of its 2021 Salix Gastrointestinal Health Scholars Program. Ten students living with a GI disease will each receive a $10,000 scholarship; a total of $100,000 in scholarships was awarded. “We created the Salix Gastrointestinal Health Scholars Program to assist students with GI conditions as they pursue their higher education goals, because we recognize that living with a GI condition can make it challenging and stressful to pursue higher education,” said Robert Spurr, president, Salix Pharmaceuticals. “We were moved by the stories this year’s recipients shared with us about how they have uniquely had to manage their GI conditions but refused to let them get in the way of their education, and we are honored to help support them.” The 2021 awardees were selected from more than 150 applications. As part of the process, applicants were required to submit essays describing how their GI condition has impacted their educational journey, as well as the role their health care provider played in helping them reach their goals. The applications were reviewed by an independent panel of judges. The Salix Gastrointestinal Health Scholars Program recognizes students across a wide range of educational pursuits, with scholarships in four categories, including the Undergraduate Scholar Awards for those pursuing undergraduate degrees; the Graduate Scholar Awards for those pursuing graduate degrees; the Working Parent’s Scholar Award for parents pursuing undergraduate, vocational/technical or graduate degrees; and the Single Parent’s Scholar Award for single parents pursuing undergraduate, vocational/technical or graduate degrees. The 2021 Salix Gastrointestinal Health Scholars Program recipients are:
“I’m so grateful to receive this scholarship as I pursue my higher education in nursing school,” said Madeleine Huwe, a recipient of the Undergraduate Scholar’s Award. “It’s wonderful to feel seen and imagine my future in health care utilizing my experience as a patient to help improve the system.” To learn more about the Salix Gastrointestinal Health Scholars Program visit www.salix.com/scholarship. The 2022 Salix Gastrointestinal Health Scholars Award will begin accepting applications in early 2022. About Salix About Bausch Health ©2021 Salix Pharmaceuticals or its affiliates.
View original content to download multimedia:https://www.prnewswire.com/news-releases/salix-announces-2021-gastrointestinal-health-scholars-program-winners-301337617.html SOURCE Bausch Health Companies Inc. | ||||||||||||
Company Codes: NYSE:BHC, Toronto:BHC |